Are companies budgeting less towards their outsourcing?

In an article at International Business Times, they say that companies have reduced their spending when it comes to outlays in outsourcing as a percentage of their clinical budget. In the study, the found that an average of 20% of the budget was reduced after each phase of the trial in research performed in 2006.

David Richardson, the lead author of the report, had this to say:
"Companies are now realizing that outsourcing does not necessarily make things easier, cheaper, or remove a burden from their plate. Research has appeared arguing against the cost-saving effects of outsourcing. Also, companies are being more frugal. Keeping things in-house grants easier oversight because of institutional proximity, ensuring efficient and competent work, instead of spending the same time managing a CRO."

Do you agree with his statement? Is this is what's happening with your clinical trial?